Related Experiment Video
Updated: Feb 20, 2026

08:52
Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
Published on: February 22, 2019
11.3K
Pertussis toxin IgA testing over-diagnoses recent pertussis infection
Meryta L May1, Jenny Evans2, Thomas Holgate2
1Sullivan Nicolaides Pathology, Brisbane, Qld, Australia; Lady Cilento Children's Hospital, Brisbane, Qld, Australia.
Pathology
|October 20, 2017
Summary
Pertussis toxin (PT) IgA testing offers limited diagnostic value for recent pertussis when combined with PT IgG assays. Isolated PT IgA results, especially in older individuals, do not reliably indicate recent infection.
Area of Science:
- Immunology
- Infectious Diseases
- Diagnostic Microbiology
Background:
- Pertussis diagnosis relies on serological markers like pertussis toxin (PT) IgG.
- The role of PT IgA in diagnosing recent pertussis infection requires further clarification.
Purpose of the Study:
- To evaluate the diagnostic contribution of PT IgA testing in conjunction with PT IgG assays.
- To assess the specificity and utility of new automated assays for PT IgA and IgG.
Main Methods:
- Evaluation of two automated assays (DiaSorin Liaison) for PT IgG and PT IgA.
- Retrospective analysis of Sullivan Nicolaides Pathology PT IgA assay results (2013-2015).
- Comparison of diagnostic specificity between PT IgG alone versus combined PT IgG and PT IgA testing.
Main Results:
- Combined PT IgG and PT IgA testing reduced specificity compared to PT IgG alone for both evaluated assays.
- An algorithm restricting PT IgA testing to equivocal PT IgG results improved specificity for the DiaSorin Liaison assay.
- Isolated PT IgA responses were uncommon and showed an age-related increase not linked to recent pertussis.
Conclusions:
- PT IgA testing provides minimal additional diagnostic value to accurate PT IgG assays in an Australian population.
- Reflex testing of PT IgA for equivocal PT IgG results may be considered if laboratory workflow allows.
More Related Videos
Related Concept Videos
Pulmonary Tuberculosis IV
559
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
559
Pneumonia III: Complications and Assessment
949
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
949
Myasthenia Gravis: Diagnostic Tests
2.8K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
2.8K
Pulmonary Tuberculosis III
1.2K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
1.2K

